Prof. Pramod K. Garg, Executive Director, Translational Health Science and Technology Institute (THSTI), inaugurated the "Advanced Nucleotide Sequencing Facility" on May 29, 2023. The facility houses state-of-the-art advanced instruments, including (i) NextSeq2000 (Illumina), (ii) MiSeq (Illumina), (iii) TapeStation system, (iv) QIAcuity digital PCR system, and (v) high computing facility. The advanced sequencing facility will serve as a central facility for genomics and metagenomics in academia and industry. The facility aims to provide better-quality nucleotide sequencing data in less time and in a cost-effective manner. Major applications will include whole genome sequencing, metagenomics, transcriptomics, and absolute quantification of nucleic acids in clinical and environmental samples.